MX2011001132A - Tratamiento acelerado. - Google Patents

Tratamiento acelerado.

Info

Publication number
MX2011001132A
MX2011001132A MX2011001132A MX2011001132A MX2011001132A MX 2011001132 A MX2011001132 A MX 2011001132A MX 2011001132 A MX2011001132 A MX 2011001132A MX 2011001132 A MX2011001132 A MX 2011001132A MX 2011001132 A MX2011001132 A MX 2011001132A
Authority
MX
Mexico
Prior art keywords
romidepsin
cancer
leu
administered
individual
Prior art date
Application number
MX2011001132A
Other languages
English (en)
Spanish (es)
Inventor
William Mcculloch
Henry Miles Prince
Original Assignee
Gloucester Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gloucester Pharmaceuticals Inc filed Critical Gloucester Pharmaceuticals Inc
Publication of MX2011001132A publication Critical patent/MX2011001132A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2011001132A 2008-07-30 2009-07-30 Tratamiento acelerado. MX2011001132A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8479708P 2008-07-30 2008-07-30
PCT/US2009/052269 WO2010014819A1 (en) 2008-07-30 2009-07-30 Accelerated therapy

Publications (1)

Publication Number Publication Date
MX2011001132A true MX2011001132A (es) 2011-08-17

Family

ID=41610730

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011001132A MX2011001132A (es) 2008-07-30 2009-07-30 Tratamiento acelerado.

Country Status (6)

Country Link
US (1) US20100152100A1 (https=)
EP (1) EP2309854A4 (https=)
JP (1) JP2011529904A (https=)
CA (1) CA2732294A1 (https=)
MX (1) MX2011001132A (https=)
WO (1) WO2010014819A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101687010A (zh) * 2006-12-29 2010-03-31 格洛斯特制药公司 制备Romidepsin
AU2007342028B2 (en) 2006-12-29 2013-06-13 Celgene Corporation Purifiction of romidepsin
BR112013004714A2 (pt) * 2010-09-01 2016-05-17 Novartis Ag "combinações de inibidores de hdac com fármacos de trombocitopenia e seus usos"
US8859502B2 (en) * 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
ES2750308T3 (es) 2015-05-22 2020-03-25 Bioiberica Proceso para preparar un extracto de cerebro de un animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2012801A4 (en) * 2006-04-24 2009-08-05 Gloucester Pharmaceuticals Inc GEMCITABINE COMBINATION THERAPY
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形

Also Published As

Publication number Publication date
WO2010014819A1 (en) 2010-02-04
US20100152100A1 (en) 2010-06-17
JP2011529904A (ja) 2011-12-15
EP2309854A4 (en) 2012-06-06
EP2309854A1 (en) 2011-04-20
CA2732294A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
US9259452B2 (en) Deacetylase inhibitor therapy
US9624271B2 (en) Romidepsin solid forms and uses thereof
US20120302520A1 (en) Gemcitabine combination therapy
EP2156846A1 (en) Prophylactic or therapeutic agent for diarrhea
US20210113601A1 (en) Agent for preventing or improving decline in brain function
MX2011001132A (es) Tratamiento acelerado.
KR20210019422A (ko) 암 치료 방법
EP2802340B1 (en) Romidepsin formulations and uses thereof
US11504355B2 (en) Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms
EP0485232A1 (en) Neovascularisation inhibitors
JP2009084211A (ja) 神経細胞賦活組成物
CA2888791C (en) Use of a combination of citrulline and glutathione in the treatment of brain damage and cognitive decline
JP5305666B2 (ja) 脈波伝播速度降下剤およびその用途
WO2023002979A1 (ja) 新規化合物およびそれを用いた末梢神経障害の予防又は改善剤
WO2022168968A1 (ja) 末梢神経障害の予防又は改善剤
JP2000007562A (ja) レトロウイルス感染に伴う免疫不全発症予防薬及び進行抑制薬
US20150216925A1 (en) Agent for preventing or ameliorating vascular endothelial malfunction
AU2015202335A1 (en) Romidepsin solid forms and uses thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal